Suppr超能文献

改良的RENAL肾计量评分在预测肾肿物射频消融成功率方面的表现。

The performance of a modified RENAL nephrometry score in predicting renal mass radiofrequency ablation success.

作者信息

Gahan Jeffrey C, Richter Michael D, Seideman Casey A, Trimmer Clayton, Chan Danny, Weaver Matthew, Olweny Ephrem O, Cadeddu Jeffrey A

机构信息

Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX.

Department of Radiology, University of Texas Southwestern Medical Center, Dallas, TX.

出版信息

Urology. 2015 Jan;85(1):125-9. doi: 10.1016/j.urology.2014.08.026. Epub 2014 Oct 18.

Abstract

OBJECTIVE

To assess the predictive performance of a modified RENAL nephrometry score for renal tumors undergoing radiofrequency ablation (RFA).

METHODS

Patients who underwent RFA were identified from 2002 to 2011, and RENAL nephrometry scoring was performed for each. A modified RENAL (m-RENAL) nephrometry score was created to account for the small sizes of tumors ablated for which the size variable, R, was adjusted. A size of 3 cm was calculated as the optimal cutoff for the R component of the m-RENAL nephrometry score, and tumors were given an R score of 1 if <3 cm, 2 if 3-4 cm, or 3 if >4 cm. Other RENAL variables were unchanged. Oncologic outcomes were stratified by complexity tertiles defined as low (4-6), medium (7-9), and high (10-12). Outcomes were reported as initial ablation success (IAS), recurrence-free survival (RFS), and metastatic-free survival (MFS). The Kaplan-Meir method was used to estimate survival based on complexity tertile.

RESULTS

Two hundred forty patients were identified who underwent RFA, of which 192 patients were eligible for analysis. Median follow-up was 32.2 months, and median tumor size was 2.4 cm. IAS was achieved in 185 of 192 patients (96.4%). Overall, the estimated 3-year RFS was 95.1% and MFS was 97.3%. There was no statistical difference between complexity tertiles using the standard RENAL nephrometry score; however, the m-RENAL nephrometry score was significantly associated with IAS and RFS (P = .027 and P = .003, respectively). There were too few events (n = 3) to perform statistical analysis for MFS.

CONCLUSION

A modification to the size variable increases the performance of the RENAL nephrometry score when used to stratify RFA ablation success.

摘要

目的

评估改良的RENAL肾计量评分对接受射频消融(RFA)的肾肿瘤的预测性能。

方法

确定2002年至2011年间接受RFA的患者,并对每位患者进行RENAL肾计量评分。创建了改良的RENAL(m-RENAL)肾计量评分,以考虑因消融肿瘤体积较小而对大小变量R进行调整的情况。计算出3 cm作为m-RENAL肾计量评分R分量的最佳截断值,肿瘤<3 cm时R评分为1,3 - 4 cm时为2,>4 cm时为3。其他RENAL变量保持不变。肿瘤学结局按定义为低(4 - 6)、中(7 - 9)和高(10 - 12)的复杂性三分位数进行分层。结局报告为初次消融成功(IAS)、无复发生存率(RFS)和无转移生存率(MFS)。采用Kaplan-Meir方法根据复杂性三分位数估计生存率。

结果

确定了240例接受RFA的患者,其中192例患者符合分析条件。中位随访时间为32.2个月,中位肿瘤大小为2.4 cm。192例患者中有185例(96.4%)实现了IAS。总体而言,估计3年RFS为95.1%,MFS为97.3%。使用标准RENAL肾计量评分时,复杂性三分位数之间无统计学差异;然而,m-RENAL肾计量评分与IAS和RFS显著相关(分别为P = 0.027和P = 0.003)。事件数太少(n = 3),无法对MFS进行统计分析。

结论

对大小变量进行修改可提高RENAL肾计量评分用于分层RFA消融成功情况时的性能。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验